Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Social Stream
JAZZ PHARMACEUTICALS PLC (JAZZ) Price Targets From Analysts
Use the tables below to see what analysts covering JAZZ PHARMACEUTICALS PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 15 | $250 | $172 | $204.937 | $120.4 | 70.21% |
| 2021-11-11 | 15 | $250 | $172 | $204.312 | $120.4 | 69.69% |
| 2021-11-16 | 15 | $250 | $172 | $204.125 | $120.4 | 69.54% |
| 2021-12-17 | 14 | $250 | $172 | $203.812 | $120.4 | 69.28% |
| 2021-12-20 | 14 | $250 | $172 | $201.937 | $120.4 | 67.72% |
| 2022-01-06 | 14 | $250 | $172 | $202.312 | $120.4 | 68.03% |
| 2022-01-13 | 14 | $250 | $172 | $202.812 | $120.4 | 68.45% |
| 2022-01-23 | 13 | $250 | $172 | $204.562 | $120.4 | 69.9% |
| 2022-02-11 | 12 | $250 | $172 | $204.437 | $120.4 | 69.8% |
| 2022-02-25 | 11 | $250 | $172 | $202.866 | $120.4 | 68.49% |
| 2022-03-02 | 12 | $250 | $172 | $202.866 | $120.4 | 68.49% |
| 2022-03-04 | 14 | $250 | $172 | $202.266 | $120.4 | 68% |
| 2022-03-28 | 14 | $250 | $174 | $203.466 | $120.4 | 68.99% |
| 2022-04-22 | 14 | $250 | $174 | $204.357 | $120.4 | 69.73% |
| 2022-04-28 | 14 | $250 | $174 | $203.785 | $120.4 | 69.26% |
| 2022-05-06 | 14 | $250 | $174 | $205.285 | $120.4 | 70.5% |
| 2022-06-02 | 15 | $250 | $174 | $203.666 | $120.4 | 69.16% |
| 2022-06-14 | 16 | $250 | $174 | $203.062 | $120.4 | 68.66% |
| 2022-08-01 | 15 | $225 | $174 | $199.933 | $120.4 | 66.06% |
| 2022-09-17 | 16 | $225 | $183 | $200.437 | $120.4 | 66.48% |
| 2022-09-21 | 16 | $225 | $148 | $197.437 | $120.4 | 63.98% |
| 2022-09-29 | 15 | $225 | $170 | $198.812 | $120.4 | 65.13% |
| 2022-10-20 | 14 | $225 | $170 | $196.933 | $120.4 | 63.57% |
| 2022-11-02 | 14 | $225 | $170 | $197.133 | $120.4 | 63.73% |
| 2022-11-30 | 16 | $225 | $180 | $199.437 | $120.4 | 65.65% |
| 2022-12-14 | 16 | $225 | $180 | $199.312 | $120.4 | 65.54% |
| 2023-02-24 | 16 | $225 | $180 | $200.125 | $120.4 | 66.22% |
| 2023-03-06 | 16 | $225 | $180 | $200.25 | $120.4 | 66.32% |
| 2023-04-14 | 16 | $225 | $180 | $201.625 | $120.4 | 67.46% |
| 2023-04-20 | 16 | $225 | $180 | $199.933 | $120.4 | 66.06% |
| 2023-04-24 | 16 | $225.001 | $180 | $201.5 | $120.4 | 67.36% |
| 2023-05-11 | 16 | $225.001 | $180 | $201.312 | $120.4 | 67.2% |
| 2023-05-15 | 16 | $225 | $180 | $201.312 | $120.4 | 67.2% |
| 2023-06-06 | 16 | $226 | $180 | $202.187 | $120.4 | 67.93% |
| 2023-06-12 | 17 | $226 | $140 | $198.529 | $120.4 | 64.89% |
| 2023-06-29 | 15 | $226 | $140 | $199.666 | $120.4 | 65.84% |
| 2023-07-04 | 16 | $226 | $140 | $199 | $120.4 | 65.28% |
| 2023-07-11 | 16 | $226 | $140 | $199.687 | $120.4 | 65.85% |
| 2023-07-13 | 16 | $226 | $140 | $200.187 | $120.4 | 66.27% |
| 2023-07-25 | 15 | $226 | $140 | $201 | $120.4 | 66.94% |
| 2023-08-11 | 15 | $226 | $140 | $203.285 | $120.4 | 68.84% |
| 2023-08-14 | 14 | $226 | $140 | $200.307 | $120.4 | 66.37% |
| 2023-10-10 | 15 | $226 | $140 | $200.307 | $120.4 | 66.37% |
| 2023-11-10 | 16 | $225 | $140 | $199.846 | $120.4 | 65.99% |
| 2023-11-27 | 16 | $225 | $135 | $194.5 | $120.4 | 61.54% |
| 2023-11-28 | 16 | $225 | $135 | $192.357 | $120.4 | 59.76% |
| 2023-12-01 | 16 | $225 | $135 | $190.357 | $120.4 | 58.1% |
| 2023-12-19 | 16 | $225 | $135 | $188.785 | $120.4 | 56.8% |
| 2023-12-21 | 16 | $225 | $135 | $187.2 | $120.4 | 55.48% |
The Trend in the Analyst Price Target
JAZZ's average price target has moved down $13.91 over the prior 37 weeks.
JAZZ reports an average of 50.37% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-21 | 16 | 225 | 180 | 200.125 | 145.02 | 38% |
| 2023-06-06 | 16 | 226 | 180 | 202.187 | 128.91 | 56.84% |
| 2023-07-04 | 16 | 226 | 140 | 199.687 | 124.14 | 60.86% |
| 2023-08-14 | 14 | 226 | 140 | 201.142 | 140.00 | 43.67% |
| 2023-12-21 | 16 | 225 | 135 | 187.200 | 121.10 | 54.58% |
JAZZ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.63 | 10 | 2 | 4 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 21 months, JAZZ's average broker recommendation rating worsened by 0.41.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, JAZZ PHARMACEUTICALS PLC's average analyst price target is greater than 5968.32% of them.
- In terms of how JAZZ PHARMACEUTICALS PLC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 5802.32% of that group.
- To contextualize these metrics, consider that out of stocks in the large market cap category, JAZZ PHARMACEUTICALS PLC's upside potential (average analyst target price relative to current price) is higher than 5685.63% of them.
- JAZZ has a lower variance in analysts' estimates than -1317.45% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, ALNY, UTHR, and BMRN are the three stocks most similar to JAZZ PHARMACEUTICALS PLC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is JAZZ a Buy, Hold or Sell? See the POWR Ratings now!